KALA BIO, Inc. - Common Stock (NQ:KALA)

0.3850 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about KALA BIO, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Short Interest Sector Focus: Healthcare Sector ↗

April 04, 2023

As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

5 Short Squeeze Stocks To Watch: Unicycle Therapeutics, Getty Images And More ↗

April 03, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits...

Via Benzinga

Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor

March 29, 2023

From Kala Pharmaceuticals, Inc.

Via GlobeNewswire

10 Short Squeeze Candidates: Unicycle Therapeutics, Compass Pathways, Virgin Orbit Among Those To Watch ↗

March 27, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

Peering Into Kala Pharmaceuticals's Recent Short Interest ↗

March 08, 2023

Via Benzinga

Kala Pharma Reveals Safety Data From Stem Cell Therapy Trial For Corneal Defect Impacting Around 240K People In Developed Nations ↗

March 27, 2023

Via Benzinga

Kala Pharmaceuticals Announces Positive Safety Update from Cohort 1 of CHASE Phase 2b Clinical Trial Evaluating KPI-012 in Patients with PCED

March 27, 2023

From Kala Pharmaceuticals, Inc.

Via GlobeNewswire

10 Short Squeeze Candidates: PaxMedica, Blue Apron, MicroStrategy And More ↗

March 20, 2023

Via Benzinga

5 Short Squeeze Candidates To Watch: Ambrx Biopharma, Kala Pharmaceuticals And This Company That Moved Up 1,403 Positions ↗

March 13, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

Kala Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference

March 08, 2023

From Kala Pharmaceuticals, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 07, 2023

Via Benzinga

Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 06, 2023

Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 06, 2023

Via Benzinga

10 Short Squeeze Candidates: China Jo-Jo Drugstores, Expion360, MoonLake, Silvergate And More ↗

March 06, 2023

Via Benzinga

What's Going On With Kala Pharmaceuticals Shares Today ↗

March 06, 2023

Kala Pharmaceutical (NASDAQ: KALA) shares skyrocketed more than 20% Monday morning on higher-than-average volume. On an average market day, Kala shares trade about 2.5 million times throughout the...

Via Benzinga

Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday ↗

March 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

What's Going On With Avalon GloboCare Shares Today ↗

March 06, 2023

The overall market ticked slightly higher in pre-market trading Monday morning, but Avalon Globocare Corp (NASDAQ: ALBT) shares really took off. Avalon GloboCare is a biotech company headquartered in...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 06, 2023

Via Benzinga

Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket ↗

March 06, 2023

Gainers Secoo Holding Limited (NASDAQ: SECO) rose 44% to $1.44 in pre-market trading after dipping over 31% on Friday.

Via Benzinga

Tesla, Nvidia, Ford, C3.ai, Kala Pharma: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

March 05, 2023

Via Benzinga

Kala Pharmaceuticals Stock Showing Rising Market Leadership; Earns 83 RS Rating ↗

March 03, 2023

On Friday, Kala Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded to 83, up from 67 a day earlier.

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 03, 2023

Via Benzinga

Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

March 03, 2023

From Kala Pharmaceuticals, Inc.

Via GlobeNewswire

10 Short Squeeze Candidates To Watch This Week: Getty, Lannett, AirSculpt And More ↗

February 13, 2023

Via Benzinga

7 Top Short-Squeeze Candidates to Watch in February ↗

February 01, 2023

For those that want to zig while others zag, these heavily targeted stocks represent the top short-squeeze candidates to watch this month.

Via InvestorPlace

10 Short Squeeze Candidates To Watch This Week: Edible Garden, Getty Images And This Stock Moving Up 1,785 Places ↗

January 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 26, 2023

Via Benzinga

Kala Pharmaceuticals, PaxMedica, Getty And Other Short Squeeze Stocks That Could Soar ↗

January 23, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 19, 2023

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.